Webcast ImageWebcast
Q4 2015 Laboratory Corporation of America Holdings Earnings Conference Call (Live)
02/18/16 at 9:00 a.m. ET
Corporate Profile

Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With combined revenue pro... More >>

Recent NewsMore >>
01/27/16LabCorp and Cheeriodicals Spread Cheer to UNC Children’s
CHAPEL HILL & BURLINGTON, N.C.--(BUSINESS WIRE)--Jan. 27, 2016-- A team from Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), along with Cheeriodicals, delivered cheer in the form of 160 big green boxes to patients at N.C. Children’s Hospital during a "Cheeriodicals Day" event held on Jan. 27. Cheeriodicals are "big green boxes of cheer" made up of, in this case, age-appropriate magazines and activity books, room decorations, puzzles, ... 
Printer Friendly Version
01/07/16LabCorp Announces New Board Member
Richelle Parham Named to the Board of Directors Effective February 8, 2016 BURLINGTON, N.C.--(BUSINESS WIRE)--Jan. 7, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) today announced that Richelle Parham has been appointed to its Board of Directors, effective February 8, 2016. “We are delighted that Richelle has accepted our invitation to join the LabCorp Board of Directors,” said David P. King, chairman and chie... 
Printer Friendly Version
01/06/16LabCorp is Scheduled to Present at the 34th Annual J.P. Morgan Healthcare Conference
BURLINGTON, N.C.--(BUSINESS WIRE)--Jan. 6, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced it will participate at the 34th Annual J.P. Morgan Healthcare Conference. LabCorp’s presentation is scheduled for Wednesday, January 13, 2016 at 11:00 AM (ET). A live audio webcast of the presentation will be available via the Company website at www.labcorp.com and archived for replay. About Lab... 
Printer Friendly Version
01/04/16Proprietary LabCorp Clinical Decision Support Report Improves Adherence to Chronic Kidney Disease Treatment Guidelines
BURLINGTON, N.C.--(BUSINESS WIRE)--Jan. 4, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced the results of a recently published clinical research study that demonstrates improved physician adherence to chronic kidney disease (CKD) treatment guidelines through the use of LabCorp’s innovative clinical decision support (CDS) report. Treatment guidelines provide evidence-based information to help physicians and ... 
Printer Friendly Version
Upcoming EventsMore >>
Q4 2015 Laboratory Corporation of America Holdings Earnings Conference Call
LH (Common)
Change Stock is Down 2.16
Intraday High$108.15
Intraday Low$105.55
Data as of 02/05/16
4:02 p.m. ET
Minimum 20 minute delay
Refresh quote

Reports & Performance

2014 Annual Report

2013 Annual Report

2012 Annual Report

2011 Annual Report

2010 Annual Report

2009 Annual Report

2008 Annual Report

2007 Annual Report

2006 Annual Report

Latest Earnings Release